New target identified to combat menopause-induced obesity

A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new study identifies potential therapies that might one day reverse these unhealthy shifts.

Cybin Inc. Announces Positive End-Of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design | Psychedelic Invest

Cybin Inc. announced a positive End-of-Phase 2 meeting with the FDA for CYB003, its deuterated psilocybin analog for the adjunctive treatment of Major Depressive Disorder

March 14, 2024

Housing is health care

Long Island is in the midst of a housing crisis. Just like in many other parts of the country, Long Islanders are having a tough

August 28, 2023

Leading Cybersecurity Companies for the Pharmaceutical Industry

When it comes to cybersecurity in the pharmaceutical industry, having an online presence means vulnerability to cyber-attacks. As cybercrime becomes more sophisticated, pharma companies are

October 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.